Studies on the role of HDAC inhibitors in reprogramming cancer cell metabolism to reverse cisplatin resistance in patient derived xenograft model of ovarian cancer | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Studies on the role of HDAC inhibitors in reprogramming cancer cell metabolism to reverse cisplatin resistance in patient derived xenograft model of ovarian cancer

Implementing Organization

Principal Investigator

Dr. V. Devi Professor Manipal University Manipal Academy of Higher Education Karnataka

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Medical Research

Start Year

2020

End Year

2021

Duration

36

Sanction Amount

₹ 9.54 L

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…